Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors' Dealings notification transmitted by DGAP - a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. ------------------------------------------------------------------------------ Details of the person subject to the disclosure requirement Last name: Dr. Pabst First name: Rainer Company: Biotest Pharmaceuticals Corporation Position: General Manager Biotest Pharmaceuticals Corp. USA Information about the transaction with duty of notification Description of the financial instrument: Preference Shares ISIN/WKN of the financial instrument: DE0005227235 Type of transaction: Buy Date: 15.05.2009 Price: 31.71 Currency: EUR No. of items: 675 Total amount traded: 21400.95 Place: Xetra Explanation for publication: 606 Shares quote 31,70 69 Shares quote 31,75 Information about the company with duty of publication Issuer: Biotest AG Landsteinerstraße 5 63303 Dreieich Deutschland ISIN: DE0005227235 WKN: 522723 End of Directors' Dealings Notification (c) DGAP 18.05.2009 Financial News transmitted by DGAP ID 9486
DGAP-DD: Biotest AG english
| Source: EQS Group AG